Cabozantinib in advanced renal cell carcinoma: a METEOR impact on clinical practice

Por Grassi, Paolo, Verzoni, Elena, Mennitto, Alessia, Procopio, Giuseppe
Publicado no Transl Androl Urol (2016)

Nivolumab in the treatment of advanced renal cell carcinoma: clinical trial evidence and experience

Por Mennitto, Alessia, Grassi, Paolo, Ratta, Raffaele, Verzoni, Elena, Prisciandaro, Michele, Procopio, Giuseppe
Publicado no Ther Adv Urol (2016)

Cabozantinib in the treatment of advanced renal cell carcinoma: design, development, and potential place in the therapy

Por Grassi, Paolo, Verzoni, Elena, Ratta, Raffaele, Mennitto, Alessia, de Braud, Filippo, Procopio, Giuseppe
Publicado no Drug Des Devel Ther (2016)

Everolimus treatment for neuroendocrine tumors: latest results and clinical potential

Por Pusceddu, Sara, Verzoni, Elena, Prinzi, Natialie, Mennitto, Alessia, Femia, Daniela, Grassi, Paolo, Concas, Laura, Vernieri, Claudio, Lo Russo, Giuseppe, Procopio, Giuseppe
Publicado no Ther Adv Med Oncol (2017)

Prognostic value of diffuse versus intestinal histotype in patients with gastric cancer: a systematic review and meta-analysis

Por Petrelli, Fausto, Berenato, Rosa, Turati, Luca, Mennitto, Alessia, Steccanella, Francesca, Caporale, Marta, Dallera, Pierpaolo, de Braud, Filippo, Pezzica, Ezio, Di Bartolomeo, Maria, Sgroi, Giovanni, Mazzaferro, Vincenzo, Pietrantonio, Filippo, Barni, Sandro
Publicado no J Gastrointest Oncol (2017)

IL-8 and eNOS polymorphisms predict bevacizumab-based first line treatment outcomes in RAS mutant metastatic colorectal cancer patients

Por Di Salvatore, Mariantonietta, Pietrantonio, Filippo, Orlandi, Armando, Del Re, Marzia, Berenato, Rosa, Rossi, Ernesto, Caporale, Marta, Guarino, Donatella, Martinetti, Antonia, Basso, Michele, Mennitto, Roberta, Santonocito, Concetta, Mennitto, Alessia, Schinzari, Giovanni, Bossi, Ilaria, Capoluongo, Ettore, Danesi, Romano, de Braud, Filippo, Barone, Carlo
Publicado no Oncotarget (2017)

GNAS mutations as prognostic biomarker in patients with relapsed peritoneal pseudomyxoma receiving metronomic capecitabine and bevacizumab: a clinical and translational study

Por Pietrantonio, Filippo, Berenato, Rosa, Maggi, Claudia, Caporale, Marta, Milione, Massimo, Perrone, Federica, Tamborini, Elena, Baratti, Dario, Kusamura, Shigeki, Mariani, Luigi, Niger, Monica, Mennitto, Alessia, Gloghini, Annunziata, Bossi, Ilaria, Settanni, Giulio, Busico, Adele, Bagnoli, Pietro Francesco, Di Bartolomeo, Maria, Deraco, Marcello, de Braud, Filippo
Publicado no J Transl Med (2016)

Location of Primary Tumor and Benefit From Anti-Epidermal Growth Factor Receptor Monoclonal Antibodies in Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer

Por Moretto, Roberto, Cremolini, Chiara, Rossini, Daniele, Pietrantonio, Filippo, Battaglin, Francesca, Mennitto, Alessia, Bergamo, Francesca, Loupakis, Fotios, Marmorino, Federica, Berenato, Rosa, Marsico, Valentina Angela, Caporale, Marta, Antoniotti, Carlotta, Masi, Gianluca, Salvatore, Lisa, Borelli, Beatrice, Fontanini, Gabriella, Lonardi, Sara, De Braud, Filippo, Falcone, Alfredo
Publicado no Oncologist (2016)

Single-Agent Panitumumab in Frail Elderly Patients With Advanced RAS and BRAF Wild-Type Colorectal Cancer: Challenging Drug Label to Light Up New Hope

Por Pietrantonio, Filippo, Cremolini, Chiara, Aprile, Giuseppe, Lonardi, Sara, Orlandi, Armando, Mennitto, Alessia, Berenato, Rosa, Antoniotti, Carlotta, Casagrande, Mariaelena, Marsico, Valentina, Marmorino, Federica, Cardellino, Giovanni Gerardo, Bergamo, Francesca, Tomasello, Gianluca, Formica, Vincenzo, Longarini, Raffaella, Giommoni, Elisa, Caporale, Marta, Di Bartolomeo, Maria, Loupakis, Fotios, de Braud, Filippo
Publicado no Oncologist (2015)